DatasetName,C2orf49_S(1) C2orf49_S(180) C2orf49_S(181),C2orf49_S(112) C2orf49_S(143) C2orf49_S(147) C2orf49_S(150) C2orf49_S(151) C2orf49_S(182) C2orf49_S(184) C2orf49_S(188) C2orf49_S(189) C2orf49_S(193) C2orf49_S(23) C2orf49_S(90) C2orf49_T(156) C2orf49_T(178) C2orf49_T(188) C2orf49_T(197) C2orf49_T(198) C2orf49_T(230)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,,0.5177440679843122
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,0.5081513707208242
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,,0.5253598878993947
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,0.5169831238260206
ZX2022_Control Replicate 2,,0.5038814146981552
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,0.5067392938500268
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,,0.5057955034262585
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,0.5109821686752739
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,0.5031663796581949
CW2012_10 µM Erl/control Experiment 1 Replicate B,,0.4866888482673449
HS2024_7_B_N1,,0.5123360199667488
FSO2013_Ratio M/L normalized Rep1___1,,0.5104764350298036
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,,0.4948290100002336
WZ2023_Pu_010_30min,,0.5200814696400773
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,,0.5141510089791096
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,,
FSO2013_Ratio M/L normalized Rep3___3,,0.4665336598267088
AH2018_TMTMS3_1_C,,0.503353972041883
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,,0.5238386823105011
AH2018_SILAC_MR_2_N,,0.5013310975726997
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,0.4965551639803999
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,,0.5096025766513639
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,,0.5035600693123752
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,,0.5095554974239047
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,,0.5019004211364476
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,,0.5170571363868486
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,0.5025707318441905
KBE2022_Log2_Ex_34_U,,
WZ2023_Pu_005_10min,,0.5173562670561445
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,0.5084900187325334
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,0.5155210867065834
WZ2023_Pu_025_30min,,0.5191376965539399
AH2018_SILAC_MR_2_X,,0.512949967208934
HS2024_4_PD_T2,,0.5213052193213663
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,,0.4588153139125648
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,0.5092379838309721
CR2017_Ratio Replicate 1.3,,0.49445333074450293
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,,0.5214468763353801
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,,0.5282295814215338
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,,0.5063206514749249
AH2018_LFQ_1_C,,0.5082985497085457
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,,0.5170483441843772
CK2022_11 40-1,,0.5085508506191377
CW2012_10 µM Erl/control Experiment 3 Replicate B,,0.4981380868163163
AH2018_SILAC_2_X,,0.5285631685183367
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,,0.5417771485776025
FSO2013_Ratio H/L normalized Rep2,,0.5143988260982248
WZ2023_Pu_005_20min,,0.5199908705402003
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,,0.46546212644471535
CW2012_10 µM Gef/control Experiment 2 Replicate B,,0.5157928902345801
HS2024_7_B_T3,,0.5048878742862175
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,,0.5082508172310594
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,,0.5100029429699683
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,,0.5161368102805947
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,0.5166773623771139
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,0.5078209242600684
CK2022_1 200-1,,0.5083332164843946
PG2020_Intensity Mock_10h_D,,0.4543424375199494
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,0.505444214660679
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,0.496654909690284
EP2017_Mitotic R#2 normalized log2 ratio,,0.4834332674919529
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,0.5184497669154984
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,0.5192858081172873
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,,0.4974669637601124
PG2020_Intensity 2h_C,,0.5042644706523816
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,0.501907774203543
KBE2022_Log2_Ex_8_T,,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,,0.5102288223200294
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,,0.5141282326247815
CK2022_3 40-1,,0.5079951875788278
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,0.515416374771612
YA2020_Reporter_intensity_Cancer_No.5,,0.5096134417541455
HH2022_Reporter intensity 8,0.5608162315374385,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,0.5043353242131546
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,,0.5162123412394154
EJN2021_5_Rest_Basal,,0.5078064707421412
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,0.5154703074071348
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,0.504899015871723
JAW2011_Ratio H/L LS2_1,,0.4828130625120489
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,0.4582370418546764
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,,0.5234810812783616
YA2020_Reporter_intensity_Normal_No.1,,0.5095512472865525
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,,0.5365701027219134
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,,0.5080677060197433
HS2024_8_I_T3,,
CF2017_EOC 3,,0.5177690739769415
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,0.5072246992596124
HS2024_6_PD_T3,,
DL2023_12h-2,,0.5104433904641873
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,,0.517552355352327
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,0.5082492181912915
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,0.5087049152340206
KS2014_Intensity N3,,0.5318810208857987
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,0.4779879808961959
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,,0.5216429400696153
FSO2013_Ratio H/M normalized Rep2,,0.490359243226698
RAM2015_Log2 A,,0.5277688998582137
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,,0.5152030298356478
KS2014_Intensity E15_2,,0.5413755618451174
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,0.5178320107816983
HS2024_7_I_T1,,0.5165512671008383
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,,0.5295962103667144
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,0.49992683514945635
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,0.5032011292426357
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,,0.49565558503198937
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,0.5041216588320154
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),0.6594903430874913,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,,0.5347481588656761
JAW2011_Ratio H/L,,0.48605955279416463
PG2020_Intensity 10h_C,,0.5111654603211341
FSO2013_Ratio M/L normalized Rep2,,0.5098045170702835
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,,0.5103160458934444
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,,0.48760709791253604
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,,0.5013257562160763
DL2023_control-1,,0.5117527296332267
AR2021_ALG 10 μM,,0.5230261047293522
JAW2011_Ratio H/L LS2_2,,0.5040080760849063
AH2018_SILAC_IT_3_N,,0.5214671141003397
EJN2021_4_Rest_Ins,,0.5093936323086792
RN2012_H05,,0.5124373084766533
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,,0.5090971232776309
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,0.5069541924702173
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,,0.5094402993183894
HH2022_Reporter intensity 3,0.7118830844858549,0.5095581959761549
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,0.5099964812076447
AH2018_SILAC_IT_1_C,,0.5276991673415574
JW2021_After_3,,
GF2025_P8_Sph,,0.49616441418068585
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,0.5129707917224734
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,,0.5275914299818462
CK2022_11 200-1,,0.5094031755783976
CK2022_12 200-1,,0.5107471212994572
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,0.6138086718689933,
WZ2023_Su_010_20min,,0.5176977515940764
AH2018_TMTMS2_2_N,,0.5056538619895989
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),0.6557849631301029,
AH2018_TMTMS3_Pool,,0.5171451767318225
KS2014_Intensity N4,,0.534953328044452
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,0.5164823613853229
CK2022_14 200-1,,0.5149130236055142
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,,0.519756710247361
AST2020_anti-CD3+PDL2.2,,0.502020970591333
PG2020_Intensity Mock_10h_A,,0.4812989790442168
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,0.5064236471167007
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,0.5166348526634185
CK2022_13 16-1,,0.5113962636120473
GF2025_P1_Adh,,0.5111174376463175
GF2025_P1_Sph,,0.5075124770135915
EJN2021_5_Ex_Basal,,0.5098460709760402
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,,0.5179879210681935
CF2017_EOC 1,,0.520534393130213
CK2022_3 200-1,,0.5084465032209133
AH2018_LFQ_IT_3_C,,0.5329304681413332
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,0.5147838946897068
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,0.5114076507437053
DL2023_12h-3,,0.5189643236824658
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,
RB2022_6_PreStrength,,
CK2022_2 40-1,,0.5087275824028388
RB2022_1_PostSprint,,
CK2022_4 200-1,,0.5089728891484925
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,0.5082850803101805
AR2021_ALG 1 μM,,0.505630451423807
HS2024_4_B_T1,,0.5026231459488841
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,0.5104956829098559
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,,0.5059788139606564
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,0.5186707488172232
GF2025_P7_Adh,,0.5137356828265726
CK2022_9 16-1,,0.5086530397877638
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,,0.5141314450626675
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,,0.5049844671364088
CK2022_16 16-1,,0.5114663258850414
FS2019_db/db3,,
CK2022_15 40-1,,0.5105886685438298
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,,0.5195690278093921
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,0.528771573737407
HS2024_5_PD_T3,,0.5102394356353719
AH2018_TMTMS3_3_X,,0.518147053778395
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,0.5248448597671387
KBE2022_Log2_Ex_40_U,,
AH2018_LFQ_M_1_N,,0.5152050171936184
KBE2022_Log2_Ex_27_U,,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,,0.5230443515484233
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,,0.5128114242291609
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,,0.4786341029430038
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,0.5095216837566723
RN2012_L13,,0.47998330189431254
LG2023_Control-1_intensity,,0.5136050391419812
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,0.5152159553413723
CW2012_10 µM Erl/control Experiment 2 Replicate B,,0.5058389661203719
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,0.502015289684495
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,0.5084292454059265
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,,0.5066542681017966
HH2022_Reporter intensity 6,0.5971626881226375,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,,0.5087683646486941
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,,0.5056477342865937
GF2025_P3_Adh,,0.5014841313248115
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,,0.5043954891591613
RM2024_Intensity D0-1___2,,
LY2019_P4+,,0.5004664186840182
KBE2022_Log2_Ex_19_U,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,0.514896023883747
YA2020_Reporter_intensity_Cancer_No.1,,0.5118823674214993
AST2020_Control,,0.5015397147659114
JAW2011_Ratio H/L LS1a,,0.5030172442927306
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,0.506805901177771
LG2023_Control-2_intensity,,0.5128933324432754
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,,0.5101991296470255
HS2024_8_B_T2,,
AH2018_LFQ_1_X,,0.508084437861888
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,,0.5331192684324975
HH2022_Reporter intensity 1,0.7130929320380978,0.5094122049398746
HH2022_Reporter intensity 2,0.7133180599934646,0.5095283533395819
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,0.5093451841449834
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,0.5105787993675108
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,0.5092731007439498
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,,0.5014211314040871
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,,0.4821337077244528
CW2012_10 µM Erl/control Experiment 2 Replicate A,,0.5031681456536194
FSO2013_Ratio H/M normalized Rep3,,0.5182171141470673
AR2021_KD 72h,,0.5341768785587511
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,,0.518300471690479
KBE2022_Log2_Ex_9_U,,
AH2018_SILAC_M_3_N,,0.5315489756694058
KBE2022_Log2_Ex_13_T,,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,,0.4802242833739094
CF2017_OSE 29,,0.5113723935406679
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,0.5130462569614176
HS2024_7_B_N2,,0.5104330657924684
PG2020_Intensity 10h_A,,0.5096779565544456
RN2012_L12,,0.5140196155923433
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,,0.5272308617982583
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,,0.5009994705088228
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,0.5086870347019565
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,0.5093440669413022
TM2022_S2.12h.B,,
RN2012_L15,,0.5083176171537
KS2014_Intensity pY_PV3,,0.4800700967917286
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,,0.48497393348157947
FSO2013_Ratio H/M normalized Rep2___2,,0.49254822862284403
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,,0.5431873436033885
RB2022_1_PreSprint,,
HS2024_4_I_N1,,
CK2022_7 200-1,,0.5091103222556431
CK2022_5 200-1,,0.5087895881272113
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,,0.5145568159277154
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,,0.5101505128179413
AH2018_SILAC_MR_1_X,,0.5012040227913713
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,,
AH2018_SILAC_3_C,,0.5272790657673373
EJN2021_5_Rest_Ins,,0.5077157261506626
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,0.4857557769168958
CK2022_4 16-1,,0.509021842666419
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,0.5058438323548271
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,0.5024475406200994
AH2018_LFQ_1_N,,0.5139077276367933
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,0.501248525538423
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,0.47629311438786853
FSO2013_Ratio H/L normalized Rep3,,0.5168061244356914
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,,
AH2018_SILAC_IT_2_N,,0.5203871371501374
AH2018_SILAC_IT_1_X,,0.5387269235363186
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,,0.5130420770486447
WZ2023_Pe_025_20min,,0.5187423996318126
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,0.5216848337886703
AH2018_LFQ_2_N,,0.5031334225757661
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,,0.5008518023116583
RN2012_H06,,0.5027509707477651
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,0.5122746895507647
WZ2023_Su_005_30min,,0.5170722949441136
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,,0.5164951173592688
WZ2023_Su_025_10min,,0.5197842208429012
AH2018_LFQ_IT_4_X,,0.5214319142769805
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,,0.5199978496142545
CW2012_10 µM Gef/control Experiment 1 Replicate B,,0.5051752640385486
SFR2015_HL_log2_ratio_avg_a,,0.5027554372652356
CW2012_10 µM Erl/control Experiment 3 Replicate A,,0.47862475160935625
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,0.5022886741398584
LG2023_GSK3α-2_intensity,,0.5153354976324582
EP2017_Pervanadate R#1 log2 ratio,,0.5064631576958002
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,,0.5388315407222356
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,,0.5233562191665742
LY2019_P7+,,0.5020271782147838
EP2017_Untreated R#1 normalized log2 ratio,,0.5174157151605692
RN2012_L10,,0.5158583406502772
PG2020_Intensity 4h_C,,0.499825095099871
EP2017_Mitotic R#3 normalized log2 ratio,,0.4832142271420692
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,0.49997058637140196
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,,
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,,0.5361931620440221
HS2024_4_B_T3,,0.5132073998836799
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,0.5045596696857003
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,0.4956618434324213
CR2017_Ratio Replicate 1.1,,0.49210256921653833
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,,0.5160360218105128
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,,0.48659798442525354
GF2025_P9_Sph,,0.5066998566324535
CK2022_6 200-1,,0.5085100678945523
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,,0.5199239544139226
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,0.5190714673118534
HS2024_4_PD_T1,,0.513911568429244
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,0.5071323726936358
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,,0.4802551328858296
EP2017_Untreated R#3 normalized log2 ratio,,0.496716511733531
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,0.48268540411912575
CK2022_8 200-1,,0.5093382383119847
KS2014_Intensity pY_C4,,0.5022568111601848
CR2017_Ratio Replicate 3.5,,0.5132719850619776
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,,0.5033947949248575
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,,0.5325419956343073
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,0.5200944069675119
KBE2022_Log2_Ex_29_T,,
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,0.48720860756789186
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,0.49163236363533247
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,,0.5095253925116745
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,,0.5116394949201288
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,0.5084342980180412
PG2020_Intensity CT_C,,0.48700455093277584
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,0.4998288521535884
KBE2022_Log2_Ex_39_U,,
EP2017_Untreated R#3 log2 ratio,,0.4980011475741113
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,,0.5150209037567545
HS2024_8_PD_T2,,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,0.5056510556735652
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,,0.5062916827935415
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,,0.5002832393702203
YA2020_Reporter_intensity_Normal_No.2,,0.5103471140302989
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,0.5203521292221013
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,,0.5449136821980479
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,0.5028840172467168
AH2018_LFQ_M_2_N,,0.5035903480237723
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,
CK2022_2 16-1,,0.5076857118714271
RAM2015_Log2 B,,0.5763655033781812
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,0.5085340206133732
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,0.5094050986723796
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,0.5128304700542574
HS2024_7_PD_T3,,0.5104755888900254
PG2020_Intensity Mock_10h_B,,0.49412989486742753
WZ2023_Su_025_30min,,0.519121471758301
AH2018_LFQ_4_N,,0.5041826669429971
CR2017_Ratio Replicate 1.2,,0.45935061567204283
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,,0.5038042616372621
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,0.5712100444726669,
AH2018_SILAC_M_1_X,,0.5233936728245941
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,0.5170528743261076
LY2019_P6+,,0.5070600295814948
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,,0.5126810574711841
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,0.527021098685985
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,,0.5181897749320827
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,,0.5419569271562521
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,0.48406331869226477
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,,0.5102369921842552
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,0.5041455168454233
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,0.5128666792626394
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,,0.5058793553527172
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,,0.5225423794076894
AH2018_LFQ_2_X,,0.5081018152505345
PG2020_Intensity 2h_B,,0.48949822444963076
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,,0.5416687446050831
GF2025_P3_Sph,,0.5030921542682993
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,,0.5253280286694882
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,0.5129412631822469
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),0.6408822789580626,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,,0.52713162052123
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,,0.4637165402313986
ZQ2022_N1,,
LY2019_P6-,,0.5037290983501013
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,0.5088966448008814
AH2018_LFQ_3_N,,0.5211823257142707
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,0.4962741905314063
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,,0.508767632655832
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,0.4946062352163434
PG2020_Intensity 4h_B,,0.525374870048926
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,,0.5084665059344509
WZ2023_Su_025_20min,,0.5213864875804135
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,,0.49912549593505656
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,0.5117784165805292
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,,0.5055533812650423
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,0.5104209753622334
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,0.5249155459461228
RN2012_H02,,0.5013165139743232
PG2020_Intensity 10h_D,,0.5062934265160091
RB2022_8_PreEndurance,,
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,,0.5087298382148959
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,0.5089202120064996
EP2017_Pervanadate R#3 log2 ratio,,0.5042253242943808
FSO2013_Ratio M/L normalized Rep1___3,,0.5297863553254489
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,,0.5154472081285064
AH2018_LFQ_M_4_C,,0.5063975651957153
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,0.5092329821569744
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,0.5064077563708109
CK2022_6 40-1,,0.507740646485064
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,
LY2019_P3-,,0.5110533490102936
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,0.507171192976083
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,,0.518076426135925
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,,0.5087237698106715
AST2020_Control.1,,0.5025841632520923
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,,0.4816118504623163
FS2019_Ctr3,,
WZ2023_Pu_025_20min,,0.5170636231871346
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,0.563007293032499
GF2025_P10_Adh,,0.5182910850723685
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,0.5090083072768655
FSO2013_Ratio H/M normalized Rep3___3,,0.4697366458320132
AH2018_TMTMS2_2_C,,0.5035366784052736
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,,0.5177557304082031
HS2024_8_I_N2,,0.4985820213406491
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,,0.527370934337803
LY2019_P8+,,0.5083665754378368
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,0.5141090007632587
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,0.49824117680983665
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),0.6499285665731459,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,,0.5075718693553237
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,0.49231067234000886
KBE2022_Log2_Ex_28_U,,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,0.5164552953318683
LY2019_P2-,,0.513273770188569
AH2018_LFQ_IT_1_X,,0.5227296506151222
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,,0.5188934655861308
AST2020_Control.2,,0.501794921820976
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,0.5416057054785488
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,0.5257679314811549
CK2022_4 40-1,,0.5084577803029657
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,0.5007313685714458
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,0.5136318402735603
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,,
AH2018_TMTMS3_3_N,,0.5165122307586341
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,0.5021033394375364
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,,0.4866032663370091
KBE2022_Log2_Ex_36_T,,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,,0.5181867148752375
KS2014_Intensity C2,,0.5425204063722286
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,,
CK2022_9 200-1,,0.5086387321049332
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,,0.5086081967852968
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,0.5186342988518301
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,,0.4978981699364062
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,,0.4718499144923223
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,,0.531532448220277
ZQ2022_C3,,
EJN2021_3_Rest_Ins,,0.5079683371796446
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,,
FSO2013_Ratio H/M normalized Rep3___2,,0.518309337137702
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,,0.5188835122686636
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,,0.5198374329635248
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,,
KS2014_Intensity N1,,0.5319054852283596
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,,0.49078122862681783
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,,0.5061865436976816
LATM2013_Log2 Ratio (Medium/Light) Forward,,0.5073454695571215
PG2020_Intensity 2h_A,,0.4836079468735072
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,,0.5150335007321921
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,0.5103121544241632
HS2024_5_B_N2,,0.5207183810002302
HS2024_5_I_N1,,0.5039038589345664
HS2024_6_I_N1,,
AR2021_KD 48h,,0.5215668517434998
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,0.5007516675948076
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,,0.518165479047863
KBE2022_Log2_Ex_29_U,,
HS2024_7_B_T1,,0.5163005269722899
AH2018_LFQ_M_2_X,,0.5147191550522943
AH2018_LFQ_IT_4_N,,0.5234796114009342
CK2022_15 200-1,,0.5147200874377752
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,,0.5257901917100437
LATM2013_Log2 Ratio (Light/Medium) Reverse,,0.4960801432190958
CK2022_2 200-1,,0.508061435137727
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,,0.5176991888457023
RN2012_H01,,0.5096016244397981
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,0.5078469888517588
KS2014_Intensity pY_E5_3,,0.4992500424099096
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,,0.5057867684286282
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,,0.511457106583892
KBE2022_Log2_Ex_44_U,,
WZ2023_Pe_010_20min,,0.5174900574308183
KS2014_Intensity pY_C6,,0.5004808519472352
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,
KS2014_Intensity C1,,0.544995430777566
FSO2013_Ratio H/M normalized Rep3___1,,0.5107635931861645
AH2018_SILAC_M_3_C,,0.5354517320106633
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,0.5172187154040863
AH2018_SILAC_M_2_C,,0.533237359116297
AH2018_SILAC_M_2_X,,0.5274774866818972
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,,0.5164305648078056
PG2020_Intensity 6h_C,,0.504763649379475
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,0.5432819630683854
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,,0.5167658897916706
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,,0.49798897805642967
CK2022_15 16-1,,0.5116421066648904
CK2022_3 16-1,,0.5076612578613697
LY2019_P4-,,0.5008605250160971
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,0.4823017709788248
HS2024_3_I_N2,,
GF2025_P8_Adh,,0.5015713598856106
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,,0.5019795667985957
CK2022_10 16-1,,0.5074652363942581
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),0.6396243457666002,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,,0.48939231775456205
EJN2021_2_Ex_Basal,,0.5085166152189742
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,
AR2021_L41 10 μM,,0.5072660205950135
CF2017_EOC 2,,0.5170494741204575
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,,0.5216273822320528
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,,0.5070606083749686
ZX2022_CB treated Replicate 1,,0.5019896336923222
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.7118450835054911,0.509524884000746
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,,0.5127404092505428
AR2021_L41 1 μM,,0.495758810899163
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,,0.5072499392531634
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,0.5515717153739834
ZX2022_Control Replicate 3,,0.4992270731378709
KS2014_Intensity C4,,0.541180049572972
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,0.4864566481977579
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,0.5060951907595496
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,,0.5024352015357765
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,0.5099243528404336
FSO2013_Ratio H/M normalized Rep2___3,,0.4621013088091299
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,,0.5231937716089867
WZ2023_Pu_025_10min,,0.5170129460771081
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,,0.5056782182720796
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,,0.5090525977609235
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,,0.5172968119144046
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,0.5278433050513462
KS2014_Intensity C6,,0.5423140355195772
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,0.5092584495912674
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,,0.5031536367894921
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,,0.5103257355573367
AH2018_SILAC_IT_2_C,,0.5246053813591457
CK2022_5 40-1,,0.507928818794851
AH2018_LFQ_3_X,,0.5029515066713006
UK2020_UA_3,,
LY2019_P7-,,0.514055527043251
GF2025_P5_Adh,,0.509028652812773
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,0.4946062352163434
FSO2013_Ratio H/L normalized Rep3___1,,0.5170033720118554
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,,0.47506486173193835
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,0.5086375258192475
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,,0.516948455098555
PG2020_Intensity CT_B,,0.47975591935904105
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,,0.496473918770753
KS2014_Intensity pY_E5_1,,0.5034279392647161
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,0.4862850047473144
RCJD2014_20min_3,,
AH2018_LFQ_3_C,,0.507690045908012
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,,0.5114067913639462
YA2020_Reporter_intensity_Cancer_No.4,,0.5123765314504266
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,,0.4946668415224918
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,,0.5105850787744017
AST2020_anti-CD3+PDL2,,0.5014447570048731
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,0.48535751488168494
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,,0.48612656442200397
AH2018_TMTMS2_1_X,,0.5117970611940635
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,0.505941531477976
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,0.5152839651351943
HS2024_4_I_T3,,0.5219827237569621
AH2018_SILAC_1_X,,0.5226910780542999
PG2020_Intensity 10h_B,,0.5122795686125463
AH2018_TMTMS3_1_X,,0.5174681311235712
CF2017_FTE 14,,0.5107130837086334
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,0.5076351746761866
PG2020_Intensity 6h_A,,0.5044208582538298
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,,
EP2017_Untreated R#2 normalized log2 ratio,,0.5004924839297988
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,,0.5122869055897378
HS2024_5_I_N2,,0.5084826523543869
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,,0.5041824458622224
AS2011_Ratio H/L Normalized RNAi_2_1,,
